- External Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiation Therapy
Radiotherapy Market size was USD 6,6805 million in 2022, growing at a 5.6% CAGR from 2023 to 2029. Radiotherapy, also known as radiation treatment, uses ionizing radiation to deliver targeted beams of radiation to cancer cells in order to kill and destroy them. The modern technology employed in radiotherapy kills malignant cells by bombarding them with radiation while causing minimal harm to the healthy cells around them. Radiotherapy is the most successful and cost-efficient cancer treatment, and when combined with new technology such as image-guided therapy, it results in improved tumor and toxicity management. The demand for radiotherapy has increased significantly in recent years due to an increase in the number of cancer patients, an increase in the geriatric population, an increase in the adoption of radiotherapy devices and procedures, an increase in the number of radiotherapy awareness campaigns, and technological advancements in radiotherapy devices. Unfortunately, a scarcity of experienced workers and difficulties in tumor visibility limit the expansion of the radiation business. Furthermore, increased demand for cancer treatment and growth opportunities in emerging markets are expected to provide numerous opportunities for market growth during the forecast period.
According to the National Cancer Institute 2020 study, an estimated 1,806,590 new cases of cancer would be identified in the United States in 2020, with 606,520 individuals dying from the disorder. Breast cancer, lung and bronchus cancer, prostate cancer, Colorectal Cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer are the most frequent malignancies. Prostate, lung, and colorectal cancers are expected to account for 43% of all malignancies diagnosed in males in 2020. Breast, lung, and colorectal cancers are the three most frequent malignancies in women, accounting for an anticipated 50% of all new cancer diagnoses in women in 2020. By 2040, the number of new cancer cases per year is predicted to reach 29.5 million, with 16.4 million cancer-related deaths. Men have a greater cancer death rate than women (189.5 per 100,000 men and 135.7 per 100,000 women). When comparing groups based on race/ethnicity and gender, African American men have the highest cancer death rate (227.3 per 100,000) while Asian/Pacific Islander women have the lowest (85.6 per 100,000). In the United States as of January 2019, there were an estimated 16.9 million cancer survivors. Cancer survivors are expected to number in the millions by 2030.
In June 2021, Elekta (Sweden) gained 510(k) approval from the US FDA for their Elekta Harmony radiation treatment system.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The advantages of radiation treatments have motivated numerous activities, including conferences and symposia, in recent years. At such gatherings, a bigger emphasis is placed on raising awareness of the advantages and therapeutic benefits that radiation provides for a variety of cancers. For instance, Portugal will host the 6th Cancer World Congress in September 2022. The sixth World Congress on Cancer in 2022 will focus on "Personalised Cancer Diagnosis and Therapy." In May 2022, the fifth Global Cancer Summit (GCS-2022) took place. under the topic "Living with cancer in the 21st century," virtually by BioGenesis Health Cluster, Bangalore, and Global Cancer Foundation. To increase understanding of and offer training for radiotherapy treatments among oncologists and radiographers, numerous radiation-related activities are planned. Such occasions are essential for spreading awareness of the benefits of various radiation techniques, which is expected to raise demand for and uptake of radiotherapy equipment.
Among types, the external beam radiotherapy segment dominated the radiotherapy market.
North America is the largest regional market for radiotherapy market.
An increase in the patient population with cancer, and a rise in the adoption of radiotherapy devices and procedures, owing to a surge in the number of awareness campaigns are some of the major factors driving the growth of the market
Some of the top players operating in the radiotherapy market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, IBA Radiopharma Solutions, BD (Becton, Dickinson and Company), Isoray Inc., Mevion Medical Systems, Nordion, Inc., NTP Radioisotopes SOC Ltd., Curium, View Ray Technologies, Inc.
1. Executive Summary |
2. Global Radiotherapy Market Introduction |
2.1. Global Radiotherapy Market – Taxonomy |
2.2. Global Radiotherapy Market –Definitions |
2.2.1. Type |
2.2.2. End User |
2.2.3. Region |
3. Global Radiotherapy Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Radiotherapy Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID 19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative and Opportunistic |
3.8. Mapping Market Players Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations and Mergers |
4. Global Radiotherapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Radiotherapy Market Forecast, By Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.1. External Beam Radiation Therapy |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Internal Radiation Therapy |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Systemic Radiation Therapy |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Radiotherapy Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.1. Hospitals and Clinics |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Other |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Radiotherapy Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Radiotherapy Market - Opportunity Analysis Index, By Type, Distribution Channel, End User, and Region, 2023 - 2029 |
8. North America Radiotherapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
8.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. External Beam Radiation Therapy |
8.1.2. Internal Radiation Therapy |
8.1.3. Systemic Radiation Therapy |
8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Hospitals and Clinics |
8.2.2. Others |
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. U.S. |
8.3.2. Canada |
8.4. North America Radiotherapy Market - Opportunity Analysis Index, By Type, End User and Country, 2023 - 2029 |
8.5. North America Radiotherapy Market Dynamics – Trends |
9. Europe Radiotherapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. External Beam Radiation Therapy |
9.1.2. Internal Radiation Therapy |
9.1.3. Systemic Radiation Therapy |
9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Hospitals and Clinics |
9.2.2. Others |
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Italy |
9.3.5. Spain |
9.3.6. Rest of Europe |
9.4. Europe Radiotherapy Market - Opportunity Analysis Index, By Type, End User and Country, 2023 - 2029 |
9.5. Europe Radiotherapy Market Dynamics – Trends |
10. Asia-Pacific Radiotherapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. External Beam Radiation Therapy |
10.1.2. Internal Radiation Therapy |
10.1.3. Systemic Radiation Therapy |
10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Hospitals and Clinics |
10.2.2. Others |
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Rest of Asia-Pacific |
10.4. Asia-Pacific Radiotherapy Market - Opportunity Analysis Index, By Type, End User and Country, 2023 - 2029 |
10.5. Asia-Pacific Radiotherapy Market Dynamics – Trends |
11. Latin America Radiotherapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
11.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. External Beam Radiation Therapy |
11.1.2. Internal Radiation Therapy |
11.1.3. Systemic Radiation Therapy |
11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Hospitals and Clinics |
11.2.2. Others |
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Argentina |
11.3.3. Rest of Latin America |
11.4. Latin America Radiotherapy Market - Opportunity Analysis Index, By Type, End User and Country, 2023 - 2029 |
11.5. Latin America Radiotherapy Market Dynamics – Trends |
12. Middle East and Africa Radiotherapy Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
12.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. External Beam Radiation Therapy |
12.1.2. Internal Radiation Therapy |
12.1.3. Systemic Radiation Therapy |
12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Hospitals and Clinics |
12.2.2. Others |
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Saudi Arabia |
12.3.2. GCC Countries |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Radiotherapy Market - Opportunity Analysis Index, By Type, End User and Country, 2023 - 2029 |
12.5. MEA Radiotherapy Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Varian Medical Systems, Inc. |
13.2.2. Elekta AB |
13.2.3. Accuray Incorporated |
13.2.4. IBA Radiopharma Solutions |
13.2.5. BD (Becton, Dickinson and Company) |
13.2.6. Isoray Inc. |
13.2.7. Mevion Medical Systems |
13.2.8. Nordion, Inc. |
13.2.9. NTP Radioisotopes SOC Ltd. |
13.2.10. Curium |
13.2.11. View Ray Technologies, Inc |
14. Research Methodology |
15. Key Assumptions and Acronyms |